Skip to Primary Navigation

Skip to main content

Pharma conference digs into Gilead case, executive orders, CMS audits

PCC 2025 conference panel featuring Sara Kimball (Daiichi Sankyo); Margaret Feltz (Purdue) and Nikki Reeves (King & Spalding)
PCC 2025 conference panel featuring Sara Kimball (Daiichi Sankyo); Margaret Feltz (Purdue) and Nikki Reeves (King & Spalding). Photo: Julie DiMauro

Julie DiMauro

<1 min read

At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.

and beyond. Let’s
, , , , , , , , , , ,

Get full access, free for a month

Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience